Developing a MAb Aggregate Removal Step by High Throughput Process Development - High throughput process development allows rapid screening of chromatographic parameters. - BioPharm International

ADVERTISEMENT

Developing a MAb Aggregate Removal Step by High Throughput Process Development
High throughput process development allows rapid screening of chromatographic parameters.


BioPharm International
Volume 23, Issue 4

OPTIMIZATION OF FLOW-THROUGH PURIFICATION

A further screening in 96-well plate format was performed for all these media to identify the chromatographic conditions to reduce the aggregate levels to <1%. The starting material had very low levels of HCPs, so these were not considered in this particular study.


Table 3. Screening conditions for flow-through purification
The MAb was loaded on the chromatography media in a range of pH values and NaCl concentrations (Table 3). After 60 min of incubation with the sample (5.3 g/L), the flow-through fractions were collected and the concentration of monomer and aggregates in the fractions was determined by SEC.




Using the monomer and aggregate concentration in the starting material (C ini,m , Cini,a) and the concentration in the flow-through fraction (Cm,Ca), the binding capacity for monomer (Qm) and for the aggregates (Qa) can be calculated according to the following equation:

For the strong anion exchanger (Capto Q), the highest capacity for both monomer and aggregates was observed at high pH values and the lowest NaCl concentration (data not shown). For all conditions, the monomer capacity was higher than the aggregate capacity. The capacity for the weak anion exchanger (Capto DEAE) leveled off at higher pH levels (8.8–9.2, data not shown). This is thought to be because of the nature of the DEAE ligand, which loses its charge around this pH, while the quaternary ammonium ions remain charged at these conditions.


Figure 1
The calculations with the multimodal medium (Capto adhere) revealed the highest capacity for both monomer and aggregates at high pH values and low NaCl concentrations, as shown in Figure 1. For phosphate, the capacity decreased with increasing NaCl concentration, and the opposite trend was seen for citrate. Given that this was a flow-through step, the objective was to identify conditions when the aggregate capacity was much higher than the monomer capacity. For all conditions, the monomer capacity was higher than the aggregate capacity, which would mean a low monomer yield in a flow-through step.


blog comments powered by Disqus

ADVERTISEMENT

Cobra Biologics Announces Development Projects
June 14, 2013
Supreme Court: Human Genes Are Not Patentable
June 14, 2013
ISPE Study Reports on Root Causes for Drug Shortages
June 12, 2013
Elan Board Rejects Multibillion Takeover Bid from Royalty Pharma
June 11, 2013
EMA Revises Biosimilars Guideline
June 11, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here